HomeTBPH • NASDAQ
add
Theravance Biopharma Inc
Previous close
$9.34
Day range
$9.25 - $9.47
Year range
$8.21 - $11.98
Market cap
459.38M USD
Avg Volume
415.16K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 17.56M | 19.91% |
Operating expense | 15.49M | -7.41% |
Net income | -8.51M | 17.87% |
Net profit margin | -48.45 | 31.51% |
Earnings per share | 0.03 | 126.36% |
EBITDA | -6.21M | 63.68% |
Effective tax rate | -69.66% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 102.43M | -68.72% |
Total assets | 382.00M | -37.11% |
Total liabilities | 169.00M | 2.06% |
Total equity | 213.00M | — |
Shares outstanding | 48.16M | — |
Price to book | 2.11 | — |
Return on assets | -3.92% | — |
Return on capital | -5.58% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -8.51M | 17.87% |
Cash from operations | -854.00K | 99.31% |
Cash from investing | -677.00K | -101.73% |
Cash from financing | -30.61M | 13.71% |
Net change in cash | -32.14M | 73.30% |
Free cash flow | 4.04M | 103.28% |
About
Founded
2013
Website
Employees
99